Dr. Edmund King Bartlett, MD

Dr. Bartlett practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Bartlett's NPI, 1821223322, was assigned on May 28, 2009. Dr. Bartlett graduated from Perelman School of Medicine at the University of Pennsylvania in 2009. Dr. Bartlett holds New York license 282689.

Dr. Bartlett's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Bartlett's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Bartlett to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bartlett practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Bartlett's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Bartlett's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists abdominal hernia repair surgery, appendectomy, cancerous skin growth removal, colon removal, esophagus, stomach, or upper small intestine surgery, groin hernia surgery and removal of damaged skin or skin graft among the conditions Dr. Bartlett treats.

CMS data shows 436 Medicare services from Dr. Bartlett across 7 procedure codes in 2024, for 280 Medicare patients. Medicare paid $43,675 for them.

CMS counts 280 Medicare patients who saw Dr. Bartlett in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bartlett's median patient age at 72, with 40% women.

In 2024, Dr. Bartlett wrote 47 Medicare Part D claims for 23 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $167 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bartlett for performance year 2024, reported as part of a group. Dr. Bartlett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bartlett as offering telehealth. CMS counts 57 procedures of melanoma (skin cancer) excision by Dr. Bartlett, more than 88% of the clinicians it reports for that procedure.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 105 papers to Dr. Bartlett, published from 2010 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Melanoma, Skin Neoplasms and Sentinel Lymph Node Biopsy. Dr. Bartlett has published most often in Ann Surg Oncol. Dr. Bartlett's most frequent co-authors are Giorgos Constantine Karakousis, MD, Douglas Leon Fraker, MD and Robert Edward Roses, MD.

Dr. Bartlett graduated from Perelman School of Medicine at the University of Pennsylvania in 2009.

Dr. Bartlett is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.